Splenic angiosarcoma following chemotherapy for follicular lymphoma.
Identifieur interne : 006606 ( PubMed/Corpus ); précédent : 006605; suivant : 006607Splenic angiosarcoma following chemotherapy for follicular lymphoma.
Auteurs : L J Zwi ; D J Evans ; A L Wechsler ; D. CatovskySource :
- Human pathology [ 0046-8177 ] ; 1986.
English descriptors
- KwdEn :
- Adult, Antineoplastic Combined Chemotherapy Protocols (adverse effects), Hemangiosarcoma (chemically induced), Hemangiosarcoma (diagnostic imaging), Hemangiosarcoma (pathology), Humans, Lymphoma, Follicular (drug therapy), Male, Splenic Neoplasms (chemically induced), Splenic Neoplasms (diagnostic imaging), Splenic Neoplasms (pathology), Tomography, X-Ray Computed.
- MESH :
- adverse effects : Antineoplastic Combined Chemotherapy Protocols.
- chemically induced : Hemangiosarcoma, Splenic Neoplasms.
- diagnostic imaging : Hemangiosarcoma, Splenic Neoplasms.
- drug therapy : Lymphoma, Follicular.
- pathology : Hemangiosarcoma, Splenic Neoplasms.
- Adult, Humans, Male, Tomography, X-Ray Computed.
Abstract
A case of splenic angiosarcoma in a patient who had been treated for a follicular lymphoma with chemotherapy over a period of about nine years is reported. The etiologic agents for angiosarcomas at various sites, and their associations with other tumors, are reviewed. The most important of these associations are radiotherapy and lymphedema with tumors of the skin and soft tissues; and vinyl chloride, arsenic, and thorium dioxide with hepatic tumors. For splenic angiosarcomas, only isolated associations with breast carcinoma and thorium dioxide exposure have been reported. In the present case long-term combination chemotherapy seems to be the most likely etiologic association.
PubMed: 3516861
Links to Exploration step
pubmed:3516861Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Splenic angiosarcoma following chemotherapy for follicular lymphoma.</title><author><name sortKey="Zwi, L J" sort="Zwi, L J" uniqKey="Zwi L" first="L J" last="Zwi">L J Zwi</name></author><author><name sortKey="Evans, D J" sort="Evans, D J" uniqKey="Evans D" first="D J" last="Evans">D J Evans</name></author><author><name sortKey="Wechsler, A L" sort="Wechsler, A L" uniqKey="Wechsler A" first="A L" last="Wechsler">A L Wechsler</name></author><author><name sortKey="Catovsky, D" sort="Catovsky, D" uniqKey="Catovsky D" first="D" last="Catovsky">D. Catovsky</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1986">1986</date><idno type="RBID">pubmed:3516861</idno><idno type="pmid">3516861</idno><idno type="wicri:Area/PubMed/Corpus">006606</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">006606</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Splenic angiosarcoma following chemotherapy for follicular lymphoma.</title><author><name sortKey="Zwi, L J" sort="Zwi, L J" uniqKey="Zwi L" first="L J" last="Zwi">L J Zwi</name></author><author><name sortKey="Evans, D J" sort="Evans, D J" uniqKey="Evans D" first="D J" last="Evans">D J Evans</name></author><author><name sortKey="Wechsler, A L" sort="Wechsler, A L" uniqKey="Wechsler A" first="A L" last="Wechsler">A L Wechsler</name></author><author><name sortKey="Catovsky, D" sort="Catovsky, D" uniqKey="Catovsky D" first="D" last="Catovsky">D. Catovsky</name></author></analytic><series><title level="j">Human pathology</title><idno type="ISSN">0046-8177</idno><imprint><date when="1986" type="published">1986</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Antineoplastic Combined Chemotherapy Protocols (adverse effects)</term><term>Hemangiosarcoma (chemically induced)</term><term>Hemangiosarcoma (diagnostic imaging)</term><term>Hemangiosarcoma (pathology)</term><term>Humans</term><term>Lymphoma, Follicular (drug therapy)</term><term>Male</term><term>Splenic Neoplasms (chemically induced)</term><term>Splenic Neoplasms (diagnostic imaging)</term><term>Splenic Neoplasms (pathology)</term><term>Tomography, X-Ray Computed</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Hemangiosarcoma</term><term>Splenic Neoplasms</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Hemangiosarcoma</term><term>Splenic Neoplasms</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lymphoma, Follicular</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Hemangiosarcoma</term><term>Splenic Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Humans</term><term>Male</term><term>Tomography, X-Ray Computed</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A case of splenic angiosarcoma in a patient who had been treated for a follicular lymphoma with chemotherapy over a period of about nine years is reported. The etiologic agents for angiosarcomas at various sites, and their associations with other tumors, are reviewed. The most important of these associations are radiotherapy and lymphedema with tumors of the skin and soft tissues; and vinyl chloride, arsenic, and thorium dioxide with hepatic tumors. For splenic angiosarcomas, only isolated associations with breast carcinoma and thorium dioxide exposure have been reported. In the present case long-term combination chemotherapy seems to be the most likely etiologic association.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">3516861</PMID><DateCreated><Year>1986</Year><Month>06</Month><Day>13</Day></DateCreated><DateCompleted><Year>1986</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0046-8177</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>5</Issue><PubDate><Year>1986</Year><Month>May</Month></PubDate></JournalIssue><Title>Human pathology</Title><ISOAbbreviation>Hum. Pathol.</ISOAbbreviation></Journal><ArticleTitle>Splenic angiosarcoma following chemotherapy for follicular lymphoma.</ArticleTitle><Pagination><MedlinePgn>528-30</MedlinePgn></Pagination><Abstract><AbstractText>A case of splenic angiosarcoma in a patient who had been treated for a follicular lymphoma with chemotherapy over a period of about nine years is reported. The etiologic agents for angiosarcomas at various sites, and their associations with other tumors, are reviewed. The most important of these associations are radiotherapy and lymphedema with tumors of the skin and soft tissues; and vinyl chloride, arsenic, and thorium dioxide with hepatic tumors. For splenic angiosarcomas, only isolated associations with breast carcinoma and thorium dioxide exposure have been reported. In the present case long-term combination chemotherapy seems to be the most likely etiologic association.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zwi</LastName><ForeName>L J</ForeName><Initials>LJ</Initials></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>D J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Wechsler</LastName><ForeName>A L</ForeName><Initials>AL</Initials></Author><Author ValidYN="Y"><LastName>Catovsky</LastName><ForeName>D</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Pathol</MedlineTA><NlmUniqueID>9421547</NlmUniqueID><ISSNLinking>0046-8177</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006394" MajorTopicYN="N">Hemangiosarcoma</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008224" MajorTopicYN="N">Lymphoma, Follicular</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013160" MajorTopicYN="N">Splenic Neoplasms</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1986</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1986</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1986</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">3516861</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006606 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 006606 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:3516861
|texte= Splenic angiosarcoma following chemotherapy for follicular lymphoma.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:3516861" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |